Biostatistics consulting services

Statistical support built for health research: trial and epidemiological design, survival analysis, regression for health outcomes, and reporting that satisfies journals and regulators.

4.9 / 5 across 1,194+ delivered projects

  • Cochrane and PRISMA 2020 methods
  • PhD methodologists
  • 100% human-written, no generative AI
  • Reproducible R and Stata code
  • Free quote within 24 hours
  • Mutual NDA on request

Our biostatistics consulting is the health-sciences specialism within our statistics work. We design clinical trials and epidemiological studies, calculate sample size for trials and cohorts, run survival analysis and regression for health outcomes, handle missing data, and write regulatory-grade reporting. It is focused on health, clinical, and biomedical research, distinct from our general statistics work and from statistics embedded in a review.

Statistics built for health and clinical research

Health data carry problems that general statistics rarely meet head on. Outcomes are often the time until an event, such as relapse or death, with patients who leave the study before it happens, which is why survival and time-to-event analysis sits at the centre of clinical work. Exposures and risks have to be separated from confounding in observational data, and missing data in a trial cannot simply be dropped without biasing the result. We bring the methods that handle these properly, rather than forcing a clinical question into a textbook test.

Design is where the gains are largest. A trial that is underpowered, or an epidemiological study that cannot control its confounders, fails before a single analysis is run. We set the study design, the primary endpoint, and the sample size so the study can answer its question and satisfy a reviewer or a regulator. For general design and analysis outside the health sciences, our broader statistical consulting service is the right starting point.

What the biostatistics service covers

  1. 1

    Clinical and epidemiological design

    We design trials and observational studies, set the primary endpoint, and calculate the sample size and power for the effect you need to detect.

  2. 2

    Survival and outcome modelling

    We run survival and time-to-event analysis, logistic and Poisson regression, and mixed models for repeated measures on your health outcomes.

  3. 3

    Confounding and missing data

    We adjust for confounding, choose a principled approach to missing data, and check the assumptions behind every model before we report it.

  4. 4

    Regulatory-grade reporting

    We write the statistical methods and results to the standard your journal or regulator expects and supply the script so the analysis is reproducible.

What you receive

You receive the analysis, the clinical figures and tables, and a statistical report written to the reporting standard your study type and submission require, each with the script so the work can be rerun and audited. Where your project pools evidence across health studies, our meta-analysis services run the quantitative synthesis, and the systematic review statistics page covers pooling and heterogeneity inside a review. If you are new to combining clinical results, our guide on how to do a meta-analysis walks through the steps, and our free effect size converter turns the statistics you have into a common scale.

  • A study design and sample-size calculation built around your endpoint
  • Survival, regression, or mixed-model analysis of your health outcomes
  • A principled approach to confounding and missing data
  • Clinical tables and figures ready for your manuscript
  • A statistical report written to your journal or regulatory standard
  • The analysis script so the work can be rerun and audited

The clinical methods we apply

Survival and time-to-event analysis

Kaplan-Meier estimation, Cox proportional-hazards models, and competing-risks methods for outcomes measured as time to an event.

Epidemiological modelling

Logistic and Poisson regression for risk, odds, and rates, with adjustment for confounding in observational data.

Trial and longitudinal designs

Randomised trial analysis and mixed models for repeated measures, with the endpoint and estimand defined up front.

Missing data and sensitivity

Principled handling of missing data and sensitivity analyses that show how robust the clinical conclusion is.

Who we support

Clinical trial teams

Investigators who need a defensible design, sample size, and analysis plan before recruitment opens.

Epidemiology and public-health researchers

Teams modelling risk and exposure in cohort, case-control, and cross-sectional data.

Clinical fellows and registrars

Doctors running a research project alongside clinical work who need the statistics handled and explained.

Regulatory and reporting submissions

Authors who need analyses and reporting prepared to the standard a journal or regulator expects.

How biostatistics support is quoted

We quote a fixed fee shaped by the study design, the analyses your endpoints require, whether the work includes survival or longitudinal modelling, and whether reporting must meet a regulatory standard. Tell us your design and your outcomes and we will return a fixed quote for the biostatistics.

General statistics support versus biostatistics

ConsiderationGeneral statisticsBiostatistics with us
Core methodsStrong on regression and standard comparisonsSurvival analysis, epidemiological modelling, and trial designs
Censored outcomesTime-to-event data often handled as a simple comparisonCensoring and competing risks modelled correctly
ConfoundingAdjustment may be limited or omittedConfounding addressed by design and in the model
Reporting standardGeneral academic reportingJournal and regulatory-grade clinical reporting

Frequently asked questions

What does your biostatistics consulting cover?
We provide statistical support for health, clinical, and biomedical research. That spans clinical and epidemiological study design, sample size for trials and observational studies, survival and time-to-event analysis, regression modelling for health outcomes, handling missing data, and reporting to the standard that journals and regulators expect. We work alongside clinical and laboratory teams from protocol through to publication.
How is this different from your general statistical consulting?
Biostatistics is the health-sciences specialism. The methods that dominate clinical and epidemiological work, such as time-to-event analysis, incidence and risk modelling, and regulatory-grade reporting, sit here. Projects in other disciplines, or general design and analysis questions, are better served by our broader statistical consulting service, and statistics inside a systematic review have their own dedicated page.
Which study designs and analyses do you support?
We support randomised controlled trials, cohort, case-control, and cross-sectional studies, and diagnostic accuracy work. Analyses include survival models, logistic and Poisson regression, mixed models for repeated measures, and methods for confounding and missing data. We work in R, Stata, SPSS, and SAS and deliver the script so the analysis is reproducible.
Can you support reporting to journals and regulators?
Yes. We write the statistical methods and results to the reporting standards your study type requires and prepare analyses to a regulatory-grade standard where a submission demands it. When reviewers raise statistical points, we revise the analysis and draft the response, continuing until the work is sound and accepted, within the agreed scope, at no extra cost.

Tell us your study design and your outcomes, and we will recommend an analysis plan and a fixed quote for the biostatistics.

Free quote within 24 hours. 100% human-written by PhD methodologists.

Methodology reviewed by

Dr Marcus Halloran, PhD

Senior Review Statistician

Runs the quantitative synthesis: pooling models, heterogeneity, network meta-analysis, and the figures that go in the paper.

Why researchers bring in a PhD methodologist

80+

systematic reviews are published every day (Hoffmann et al., 2021)

67.3 weeks

average time to complete a review in-house (Borah et al., BMJ Open 2017)

~70%

of published reviews rate critically low on AMSTAR 2 quality appraisal

4.9 / 5

our client rating across 1,194+ delivered projects